HSP27 as a biomarker for predicting skin irritation in human skin and reconstructed organotypic skin model
Casey Halperns deep-dive on Huberman Lab into deep brain stimulation for OCD and addiction fits this theme: precision circuit-targeting is replacing blunt pharmacology across neurology, not just cardiology
Research findings include: BPC-157 specific : Protection against ethanol and stress-induced mucosal damage
Overall, the trial demonstrated that once-weekly Cagrilintide induced clinically meaningful, dose-dependent weight loss in adults with overweight or obesity, with efficacy comparable or superior to liraglutide 3.0 mg
The exact dose depends on the patients condition and how they respond to treatment
Factors that influence this include: Baseline B12 levels Symptoms and severity Absorption issues or medical conditions Diet and lifestyle factors Some people maintain healthy levels with occasional injections, while others require more consistent support
